Comments

Kiniksa Pharmaceuticals Stock Guidance

KNSANASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$29.06
0.341.18%
At close: -
$29.84
0.782.68%
After Hours: 6:49 PM EDT
Kiniksa Pharmaceuticals (KNSA) ForecastNewsEarningsKiniksa Pharmaceuticals (KNSA) Options

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Kiniksa Pharmaceuticals Stock Guidance | NASDAQ:KNSA | Benzinga

Kiniksa Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
04/29/2025KNSA
Kiniksa Pharmaceuticals
FY2025———$590.00M$605.00M$577.59MGet Alert
02/25/2025KNSA
Kiniksa Pharmaceuticals
FY2025———$560.00M$580.00M$581.43MGet Alert

FAQ

Q

What is the most recent guidance for Kiniksa Pharmaceuticals (KNSA)?

A

There have been no specific sales or earnings guidance reported for Kiniksa Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved